Our group has reported that the blockade of BAFF through belimumab therapy or blocking of IL-21 signaling plays critical roles in the generation of CD4+CD25+Foxp3+ Treg cells in acute GVHD after allo-BMT (Figure 3C) (9). Here, IL21 is linked to acute graft versus host disease.